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Manufacturing of custom-made medical implants for
cranio/maxillofacial and orthopaedic surgery – an
overview of the current state of the industry
N. de Beer, D. Dimitrov and A. van der Merwe
Extensive work has been done in the area of manufacturing implants for
medical purposes, and more recently the development of customised
implants. Areas of application include cranio/maxillo-facial implants, dental
drill guides, hip, knee and shoulder replacements, as well as different implants
for the spine. Due to their high prevalence and complex anatomical geometry
the purpose of this study is to investigate the current state of the industry
regarding customised medical implants for cranio/maxillofacial and
orthopaedic surgery. Implant customisation has far-reaching benefits, and a
collective approach to solving current difficulties will require an in-depth study
of successes already achieved. Several issues in this regard are examined,
including what defines customisation, regulatory issues that govern
customisation and design constraints, trends in different areas of application,
suitable materials, and finally which manufacturing techniques are being
employed, with a focus on the use of Layer Manufacturing technologies and
their role in custom-made medical implants.
Medical models, Customised implant, Layer Manufacturing
Over the last decade there has been a growing interest among physicians in
the technology of medical models for the purpose of facilitating diagnosis, pre-
operative planning and communication between colleagues and patients. An
ability to create tangible models from medical imaging data (e.g. Computed
Tomography (CT) and Magnetic Resonance Imaging (MRI)) has proven
highly advantageous, especially within the field of craniofacial surgery where
planning and performing an operation are extremely difficult due to the
complex and variable anatomy. Historically, the uses of medical models by
surgeons wanting to pre-plan surgery have fallen into the following five
categories [1]:
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2• Visualisation of the patient's anatomy before treatment or surgery.
• Surgery or treatment simulation (actual cutting or measuring on the
model) before intervention.
• Creation of custom implants, templates, or guides prior to surgery.
• Enhanced communication with others involved in patient treatment and
their related staff.
• Improved communication and consent by the patient and patient's
family concerning the upcoming procedure.
Many successful case studies have been done in these areas, with prominent
examples from work by the Phidias Network [2] and others. The RP4Baghdad
project, initiated in June 2005, has through its contributions also documented
an extensive case study base of medical models produced [3]. What is
however evident from these case studies, is the fact that the majority relate to
applications in the cranio/maxillo-facial areas, and that medical models were
produced for either surgical planning and communication or for the purposes
of producing an implant through indirect methods [12, 14, 15]. With the advent
and growth of the ability to produce end-use metal components using Layer
Manufacturing (LM), direct methods for implant manufacturing have gradually
emerged. These improvements in materials and manufacturing methods
have been well supported by a growth in necessary software to convert,
simulate and prepare imaging data for medical modelling. In addition, they
have enhanced the process of implant manufacturing by facilitating the design
stage to enable customised implant geometry to match the relevant anatomy
interfaces. This powerful combination – to develop customised CAD
(Computer-Aided Design) models and subsequently produce complex
geometry in final use materials by means of Layer Manufacturing – has
enabled wide and far-reaching potentials for future implant manufacturing.
Before medical implants are approved, they are required to comply to a
stringent set of regulations. With the continuous growth and demand for new
medical devices, the need for corresponding regulations has also increased,
[4, 5, 6, 7, 11], and while current regulations are making provision for new
medical devices, there is still some work to be done to accommodate the
growth in, especially, the use of customised medical implants, [8, 9, 10].
The Food and Drug Administration (FDA) of the United States of America
has recognised three classes of medical devices based on the level of
control necessary to assure the safety and effectiveness of the device. The
classifications are assigned according to the risk the medical device
presents to the patient and the level of regulatory control the FDA
determines is needed to legally market the device.
2. CLASSIFICATION FOR IMPLANT CUSTOMISATION AND
REGULATORY ISSUES
2.1 General Classification
As the classification level increases, so does the risk to the patient, and also
FDA regulatory control. Class I devices have the least amount of regulatory
control and present minimal potential for harm to the user. Class I devices are
typically simple in design, manufacture and have a history of safe use.
Examples of Class I devices include tongue depressors, arm slings, and
hand-held surgical instruments.
Class II medical devices are devices where general controls are not sufficient
to assure safety and effectiveness and existing methods/standards/guidance
documents are available to provide assurances of safety and effectiveness. In
addition to compliance with general controls, Class II devices are required to
comply with special controls. Special controls include for example, special
labelling requirements, mandatory performance standards and post-market
surveillance. Examples of Class II devices include physiologic monitors, x-ray
systems, gas analysers, pumps, and surgical drapes.
Class III medical devices have the most stringent regulatory controls. They
usually support or sustain human life, are of substantial importance in
preventing impairment of human health, or present a potential unreasonable
risk of illness or injury to the patient. General or specific controls are not
sufficient to regulate Class III devices, and a Pre-Market Approval (PMA)
submission to the FDA is typically required to allow marketing of a Class III
medical device. Examples of Class III devices that require a PMA are:
replacement heart valves, silicone gel-filled breast implants, and implanted
cerebella stimulators.
The classification of medical devices in the European Union (EU) is outlined in
Annex IX of its Medical Devices Directive 93/42/EEC [4]. The European
classification depends on rules that involve the medical device's duration of
body contact, its invasive character, its use of an energy source, its effect on
the central circulation or nervous system, its diagnostic impact or its
incorporation of a medicinal product. Similar to the FDA classification, the EU
basically defines four classes (Class I, IIa, IIb, and III), ranging from low risk to
high risk. Medical implants will fall into Class III for both FDA and EU
classification.
Within the context of medical devices, theActive Implantable Medical Devices
Directive (90/385/EEC) defines a custom-made device as “any active
implantable medical device specifically made in accordance with a medical
specialist's written prescription which gives, under his responsibility, specific
design characteristics and is intended to be used only for an individual named
patient” [5]. This definition is also supported by the Medicines and Healthcare
products RegulatoryAgency (MHRA) that regulates medical devices in the UK
under European legislation [6] and the FDA according to its Code of Federal
Regulations, Title 21, Volume 8 [7].
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Conventional procedures for implant design have in the past been limited to a
process of selecting standard size replacement parts from a range provided
by manufacturers based on anthropomorphic data. This works satisfactorily
for some types of procedures, but there are always patients outside the
standard range, between sizes, or with special requirements caused by
disease or genetics. Therefore as technology increases to provide more
options to surgeons, so there is a growing need for producing custom-made
implants. The authors suggest that implant customisation may largely be
divided into two main groups, namely:
• Custom-size and
• Custom-fit implants
Custom-size refers to the custom manufacture of “in-between-size” implants
that have been manufactured from the same original implant design, but
scaled appropriately per patient. Custom-fit implants on the other hand denote
redesign and manufacture of part geometry to match a patient's specific
anatomy. The term “custom-made” then refers to the process or action of
producing either a custom-size or custom-fit medical implant.
The degree to which implant customisation takes place is largely dictated by
the area of application. Cranio/maxillo-facial implants, for example, by virtue
of their complex geometry, require tailored designs to fit at the implant
location, and this implies a need for custom-fitting. A hip replacement on the
other hand, may require less customisation to the implant design while its
function remains the same for different patients. Nevertheless, custom-sizing
is still justified due to wide variability in patients' anatomy.
Although implants can now be manufactured so that their geometry matches
the geometry of anatomical features, the importance of implant function and
efficacy is a consideration that cannot be overlooked. Customisation may in
fact pose opportunities to improve functional restoration in addition to
geometric fit. Within this context, international quality standards, protocols
and medical regulations are in place to ensure safety for patients regarding
any undue practices. In cases where custom sizing is involved, conventional
procedures demand a set of rigorous testing and clinical trials to be conducted
before an implant design may be commercialised. In cases where one-off
custom fit implants for individual patients are produced and inherently differ
from previously tested existing designs, a situation arises where extended
rigorous testing and clinical trials becomes impractical. A question therefore
arises as to how to balance the design and manufacture of custom-fit implants
while at the same time performing adequate testing prior to implantation.
2.2 Regulatory issues
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The medical device market is unfortunately not very well regulated in South
Africa. Medical equipment – other than electro-medical devices – including
disposable or single use devices, are not regulated. The Hazardous
Substances Act (Act 15 of 1973) of the Department of Health is used to
regulate electro-medical devices that fall within a so-called Group III
classification (note that Group III classification here differs from Class III
previously mentioned). If any product does not appear on the current
Schedule of Listed Electronic Products [10], such products are under no legal
requirement from the South African Department of Health in terms of
importing, manufacturing or distribution [8, 9]. Currently, medical implants do
not appear on this schedule [10], and are therefore at this stage exempt. The
Department of Health is in the process of drafting the necessary policy
documents and has indicated that these may become available in the near
future. In the absence of local regulations, international regulations should
therefore be considered and adhered to.
In order to simplify the process of approval for product developers,
international efforts towards collaboration in regulating medical devices are
making progress. In 1992 an international forum, the Global Harmonization
Task Force (GHTF), was formed, embarking on a number of regulatory
initiatives designed to move the participating countries closer to achieving the
goal of mutual recognition of regulatory processes. As regulations are
continuously being updated to reflect new developments in this industry,
custom-made devices are becoming more recognised and incorporated in
these documents. In its most recent update, the European Commission has
published an important amendment to the Medical Devices Directive [11]. This
amendment Directive 2007/47/EC gives member states an opportunity to
comply and doesn't come fully into force until 21 March 2010. It introduces
more than 150 changes that range from simple text corrections, to introduction
of new requirements. Directive 2007/47/EC is the fifth document that
introduces amendments to the original text of the Medical Devices Directive
93/42/EEC [4].
In review of current regulations, provision is therefore made for the design and
manufacture of custom-made implants. Further requirements for custom-
made devices are set out in Annex I of the Medical Devices Directive
93/42/EEC [4], of which the details fall beyond the scope of this article.
Over the last decade several LM technologies have emerged that are showing
notable promise in their ability to directly manufacture customised implants in
final, end-use materials. Direct metal fabrication processes can be grouped
into three categories [1]. The first group describes systems that use a laser to
heat powder to form metal parts. All of the systems in this group produce parts
in a powder bed, such as for example, Direct Metal Laser Sintering and
LaserCusing.
3. METAL PROCESSING LM TECHNOLOGIES
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The second group includes systems that use a powder deposition head to
deposit the metal powder, such as Direct Metal Deposition. The third group
consists of systems that use special approaches to produce metal parts and
that do not fit into the first two groups, e.g. Direct Metal Printing (from
ProMetal).
LM System developers are investing a lot of effort to improve the quality of
metal parts produced according to these systems in order to meet customer
requirements and deliver components by means of Rapid Manufacturing
(RM). Specific emphasis has been placed on the ability to deliver 100%
dense, high strength parts with superior surface finish for engineering
applications. Apart from the need for high strength parts, medical implants
however do not always share the same emphasis on part quality
requirements. The essential material issues in the medical field relate mostly
to biocompatibility. In many cases poor surface finish and porosity is a
desirable feature for implants to allow bone ingrowth. In other cases where
articulating surfaces (such as knee or hip joints) are involved, surface
roughness must be very low. Also, accuracy in medical terms is usually
quantified in millimetres with only selected situations (e.g. some dental
applications) requiring more narrow tolerances. What is of more interest is an
ability to create very detailed features. In medical models for example, the
inclusion of fine features such as arteries, nerves and small bones are critical
for accurate and proper representation during pre-surgical planning.
A selection of metal fabrication LM technologies have been taken from
Wohlers [1] and placed in Table 1 with a comparison of characteristics and key
areas for medical application.
System [1] Characteristics [1] Key Application Area
Key Process Company Materials
Detail
Ability
(mm)
Cranio/
maxillofacial
Dental
Orthopaedics
(Hip, Knee,
Shoulder)
Other
Direct Metal
Laser Sintering
(DMLS)
EOS
GmbH
Metal powder
blends
0.6 √ √ √ √
Electron Beam
Melting (EBM)
Arcam
Powder
metals
0.25 √ √ √ √
LaserCUSING
Concept
Laser
Powder
metals: SS;
Tool steels; Ti;
Al
0.4 √ √ √ √
Selective Laser
Melting
F&S/ MCP
Non
proprietary;
SLM
processes any
metal powder
(10 to 75
micron
particles)
< 0.2 √ √ √ √
Table 1: Metal fabrication comparison matrix suitable for medical applications
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4. AREAS OF APPLICATION
4.1 Cranio/maxillo-facial
The following section describes a number of examples for different areas of
applications that can serve to illustrate how custom implants are currently
being used. The cases shown do not cover all possible applications and are
not necessarily the best examples in each application sector. Rather they
serve to illustrate the processes involved and technological capabilities
available.
Cranioplasty
Cranioplasty is the surgical correction of skull defects. The two major
purposes of performing a cranioplasty operation are to protect the brain and to
provide restoration for cosmetic purposes. In this field, medical models are
used for pre-operative planning, as a template for preparing implants, and as a
master implant for making a mould from which the implant is fabricated.
Current cranioplasty materials include autologous or homologous bone grafts
(a bone transplant from either the same patient or another person
respectively), wire mesh and methyl methacrylate, plastics, and metals, either
alone or in combination [12]. The ideal material for cranioplasty prostheses
construction must be resistant to corrosion and abrasive wearing,
biocompatible, eliminate the risk of inflammation, rejection and infection, and
must be integrable with the living bone structure to the point of becoming a part
of it, promoting osteoblast migration (migration of cells that are responsible for
the forming of bone) [14]. Over the past quarter-century, the popularisation of
numerous alloplastic materials has favoured them over autologous bone
because of the absence of need to harvest donor bone, and particularly
because of bone's tendency to resorb or scar [13].
As an alternative, hydroxyapatite-based ceramics, which may induce bone
growth into the implant, are increasingly being used because
polymethylmethacrylate (PMMA), high density ceramics, titanium and other
resin and alloy types do not fully meet the material target requirements [14].
Apart from their own study which involved a review of 25 cases over a period of
seven years, Staffa et al. [14] include an epidemiological study of post-
surgical cranial defects and its reconstructive treatment which was conducted
in Italy, in an attempt to link human health effects to specified causes. This was
accomplished through a questionnaire sent to all Italian neurosurgery
departments in the year 2000. With 47% response, these departments
indicated that comminuted fracture (a fracture in which there are two or more
bone fragments) (41%) and decompressive operculectomy (the surgical
removal of the operculum) due to oedema (swelling due to fluid under the skin)
(28%) are the main causes of post-surgery craniolacunae (disorganised
formation of collagen).
4.1.1
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Trauma is involved in more than 60% of all procedures to remove parts of the
skull [14]. Despite the growth towards using alloplastic materials and
hydroxyapatite-based ceramics, the most common material reportedly used
(Figure 1) was still heterologous PMMA (i.e. an implant not derived from the
patient's body).
Staffa et al. [14] present a case study of their process using hydroxyapatite as
implant material. The process that they follow requires firstly the manufacture
of a medical model of the existing skull and fracture (Figure 2.a) – in their case
using Stereolithography (SL). Secondly, an initial sample implant equal to the
patient's bone defect is produced (Figure 2.b), which is used to craft an implant
equal to the approved model from a block of porous hydroxyapatite (Figure
2c), which is then surgically implanted (Figure 2d).
All patients underwent clinical follow-up and a 3D CT scan 6–9 months after
surgery. Follow-up indicated that there were no infective complications,
reabsorption, rejections or spontaneous fractures. The mean time in the
operating theatre was reduced from around 150 min (with implants produced
in the operating theatre) to 90 min for the pre-manufactured hydroxyapatite
prosthesis.
Titanium
mesh
10%
Autologous
bone
26%
PMMA
53%
Hydroxy-
apetite
6%
Polyester
2%
Titanium
plate
1%
Other
2%
Figure 1: Materials commonly used to create cranioplasty implants [14]
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4.1.2 Reconstructive surgery
Another area in which medical models and custom implants have proven very
beneficial is facial reconstructive surgery. A number of causes – notably bone
tumours or congenital defects – may result in situations requiring surgical
intervention. Singare et al. [18] combined rapid prototyping (RP) and
investment casting techniques to fabricate a customised titanium-alloy
mandible substitute and filled it with autograft to repair the damaged mandible.
Another recent case involved a local male patient with a bone tumour causing
severe damage to his mandible (Figure 3). Conventional surgical procedures
were followed, making use of bone grafts and plates to reconstruct the lower
jaw. A retrospective case study is however being performed in collaboration
with the surgical specialist, Dr Jean Morkel, head of the Department of
Maxillo-Facial and Oral Surgery & Anaesthesiology and Sedation of the
University of the Western Cape, to investigate the benefits obtained from
having a medical model prior to surgery for planning or as a template on which
a graft may be directly shaped intra-operatively. With this approach, the
operating time can be dramatically reduced because the surgeon can shape
the bone graft on the biomodel while the assistant simultaneously prepares
the exposure of the donor site.
(a) Medical model using Stereolithography
(b) Medical model with initial sample
implant
(c) Hydroxyapatite-based implant fitted to
model
(d) Surgical implantation
Figure 2: Preparation and surgery of hydroxyapa ite-based ceramic cranial implant [14]
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(a) Anterior view (b) Inferior view
Figure 3: Medical model of patient case with large bone tumour
Alternatively, when the graft requires a fairly complex shape, acrylic, or a
similar material, can be used pre-operatively to create a master implant to
serve as a guide for shaping the bone graft intra-operatively. The surgeon can
minimise surgery time by pre-operatively moulding the acrylic to the exact
shape required, using the biomodel as a template [15].
The science of hip and knee replacements (arthroplasty) has certainly come a
long way since the first successful ivory implants of Dr San Baw in the 1960s.
With the development of material processing technologies, a range of
substitutes for load-bearing components have been created by combining
different materials and advanced engineering techniques. Some researchers
coated calcium phosphate onto metallic implants using plasma-spraying
techniques and studies have shown good fixation to the host bone and
increased bone ingrowth to the implants [16, 17]. Another example of
improved techniques using advanced engineering methods is a case
presented by He et al. [19]. They show a custom design and fabrication
method for a novel composite hemi-knee joint implant, which consists of a
titanium-alloy hemi-knee joint component and a porous-bioceramic artificial
bone, using a dog as research subject. The process that was followed (Figure
4) included data collection through CT scanning and image reconstruction of
this data to create a 3D model of the femur bone (Figure 4a-c). A Reverse
Engineering (RE) process was performed to derive surface recreations of the
model for further design and customisation. These RE models were then used
to design two 3D models (Figure 4e-f and Figure 4g-i) that were later
reproduced using Stereolithography (SL).
4.2 Hip and  knee replacements
in vivo
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One was a negative model from which to create the porous-bioceramic
artificial bone, and the other a solid model of the hemi-knee implant itself.
Figures 5a and c show these SL models respectively. The negative SL pattern
of the artificial bone was further processed by filling it with porous beta-
tricalcium phosphate ( -TCP), which is a biocompatible and biodegradable
material. The -TCP-filled pattern was then sintered into a porous bioceramic
scaffold (Figure 5d), burning out the resin material. The other SL pattern of the
hemi-knee implant was used to produce the final hemi-knee implant (Figure
5b) by means of investment casting in Ti-6Al-4V.
Postoperative results are reported to be very successful.After two months, the
normal function of the damaged joint began to restore and the composite
prosthesis maintained its original shape, which indicated sufficient
mechanical strength. These results suggest that this fabrication method could
create a composite hemi-knee joint prosthesis for individuals with enough
mechanical strength and it can potentially be applied to the fabrication of other
customised artificial implants such as the hip or shoulder too.
Although He et al. [19] and other researchers are reporting successful results
in applying RP and RM technologies for implant manufacture, it is important to
keep in mind some limitations which will influence a selected process. Cost is
one such important consideration. Even where there are obvious benefits in
terms of improving the medical service, the approach may still be cost
prohibitive. RM can be an option for high-cost, customised, complex-
geometry parts, and ideally RP technologies are suited to situations where it
would be difficult or impossible to produce the component using more
conventional manufacturing techniques. In addition to cost, material
properties are another important consideration.
Very few RP materials are presently biocompatible while many are not even fit
to be sterilized and taken into operating theatres. But researchers into RP and
RM processes are aiming to develop components to include multiple
materials (and/or functional gradients of multiple materials) as well as
electronic components and features. Should this be achieved, a significant
contribution will be made to create medical devices with intelligent sensors
while at the same time matching an individual patient's body and needs.
Journal for New Generation Sciences: Volume 6  Number 211
Figure 4: Process chain for custom design of composite hemi-knee joint substitute [19]
(a) RP Pattern (b) Titanium-alloy implant
(c) RP Negative pattern (d) Porous-bioceramic artificial bone
Figure 5: Hemi-knee joint implant and artificial bone before and after sintering
process [19]
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5. CONCLUSIONS
6. REFERENCES
The use of Layer Manufacturing technologies combined with cross-cutting
disciplines to serve the medical field is a highly interesting and rewarding
branch of research. With the advancement of new techniques for custom
fabrication of implants in combination with clinical experience and innovative
developments in materials, the potential for improved surgical procedures
looks very promising.
Different combinations of materials and techniques are however still being
investigated and more cases, especially in the area of direct metal implant
fabrication through Rapid Manufacturing, must be presented and evaluated.
The technology cannot be applied for every case, and capability studies are
needed to identify specific scopes of application per technology.
In parallel to a continuous drive for finding better ways to produce medical
implants, the issues surrounding regulation and control of manufacturing
customised implants should not be neglected. Technological advancement in
the medical field must be supported by appropriate legislation, otherwise
application of new technology may be restricted, or patients may potentially
suffer as a result of undue practices.
Several avenues for future development in this field lie wide open. LM as an
enabling technology should be seen as a tool to produce physical models for
different needs. A critical factor in the successful application of LM in the
medical field will be a matching and supportive development of suitable
materials or combinations thereof for clinical use in the body. It is therefore not
surprising that so much research effort is being applied in the area of Tissue
Engineering and scaffold development. These efforts are indeed justified, and
this study recommends continued further investigations into these fields.
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